Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy
Open Access
- 12 May 2025
- journal article
- Published by Elsevier in Kidney International Reports
- Vol. 10 (8) , 2800-2804
Abstract
No abstract availableKeywords
Funding Information
- H2020 European Research Council
- Bundesministerium für Forschung, Technologie und Raumfahrt (STOP-FSGS- 01GM2202A)
- Deutsche Forschungsgemeinschaft (TO1013)
- European Research Council
- Else Kröner-Fresenius-Stiftung
- European Commission
This publication has 11 references indexed in Scilit:
- Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategyKidney International, 2025
- Passive transfer of patient-derived anti-nephrin autoantibodies causes a podocytopathy with minimal change lesionsJournal of Clinical Investigation, 2024
- Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressantsKidney International, 2024
- Kidney Disease and Antinephrin AntibodiesNew England Journal of Medicine, 2024
- Autoantibodies Targeting Nephrin in PodocytopathiesNew England Journal of Medicine, 2024
- Anti-nephrin autoantibodies: a paradigm shift in podocytopathiesNature Reviews Nephrology, 2024
- Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus NephritisKidney International, 2024
- Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidenceKidney International, 2022
- Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune EtiologyJournal of the American Society of Nephrology, 2022
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular DiseasesKidney International, 2021